242 related articles for article (PubMed ID: 26483428)
21. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
22. Exploiting CD1-restricted T cells for clinical benefit.
Exley MA; Dellabona P; Casorati G
Mol Immunol; 2021 Apr; 132():126-131. PubMed ID: 33582549
[TBL] [Abstract][Full Text] [Related]
23. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
24. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody.
Patel NP; Guan P; Bahal D; Hashem T; Scheuplein F; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560408
[TBL] [Abstract][Full Text] [Related]
25. Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.
Crosby CM; Kronenberg M
Immunogenetics; 2016 Aug; 68(8):639-48. PubMed ID: 27368411
[TBL] [Abstract][Full Text] [Related]
26. The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.
Peng Y; Zhao L; Shekhar S; Liu L; Wang H; Chen Q; Gao X; Yang X; Zhao W
Cell Mol Immunol; 2012 Jul; 9(4):361-6. PubMed ID: 22728762
[TBL] [Abstract][Full Text] [Related]
27. Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment.
Singh D; Ghate M; Godbole S; Kulkarni S; Thakar M
Front Immunol; 2018; 9():1152. PubMed ID: 29881390
[TBL] [Abstract][Full Text] [Related]
28. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
29. Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.
Mannik LA; Chin-Yee I; Sharif S; Van Kaer L; Delovitch TL; Haeryfar SM
Immunology; 2011 Mar; 132(3):361-75. PubMed ID: 21070234
[TBL] [Abstract][Full Text] [Related]
30. Novel in vitro invariant natural killer T cell functional assays.
Balasko A; Graydon C; Fowke KR
J Immunol Methods; 2021 Dec; 499():113171. PubMed ID: 34706265
[TBL] [Abstract][Full Text] [Related]
31. Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer.
Ascui G; Gálvez-Jirón F; Kramm K; Schäfer C; Siña J; Pola V; Cristi F; Hernández C; Garrido-Tapia M; Pesce B; Bustamante M; Fluxá P; Molina MC; Ribeiro CH
Immunol Cell Biol; 2020 Jul; 98(6):500-513. PubMed ID: 32189398
[TBL] [Abstract][Full Text] [Related]
32. Globotriaosylceramide inhibits iNKT-cell activation in a CD1d-dependent manner.
Pereira CS; Sa-Miranda C; De Libero G; Mori L; Macedo MF
Eur J Immunol; 2016 Jan; 46(1):147-53. PubMed ID: 26426881
[TBL] [Abstract][Full Text] [Related]
33. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.
Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445
[TBL] [Abstract][Full Text] [Related]
34. Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity.
Albacker LA; Chaudhary V; Chang YJ; Kim HY; Chuang YT; Pichavant M; DeKruyff RH; Savage PB; Umetsu DT
Nat Med; 2013 Oct; 19(10):1297-304. PubMed ID: 23995283
[TBL] [Abstract][Full Text] [Related]
35. CD1d and invariant NKT cells at the human maternal-fetal interface.
Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486
[TBL] [Abstract][Full Text] [Related]
36. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
37. Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.
Laurent X; Bertin B; Renault N; Farce A; Speca S; Milhomme O; Millet R; Desreumaux P; Hénon E; Chavatte P
J Med Chem; 2014 Jul; 57(13):5489-508. PubMed ID: 24428717
[TBL] [Abstract][Full Text] [Related]
38. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
[TBL] [Abstract][Full Text] [Related]
39. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
[TBL] [Abstract][Full Text] [Related]
40. Species-specific activity of glycolipid ligands for invariant NKT cells.
Dangerfield EM; Cheng JM; Knight DA; Weinkove R; Dunbar PR; Hermans IF; Timmer MS; Stocker BL
Chembiochem; 2012 Jun; 13(9):1349-56. PubMed ID: 22639457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
